Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.24.1.u1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Schedule of number of cash-settled RSUs granted

​

​

​

​

​

​

​

​

Three months ended

​

​

​

​

March 31, 2024

​

​

​

​

RSUs Granted (000's)

​

​

​

​

​

​

​

QRTEA time-based RSUs, subsidiary employees (1)

​

20,945

​

​

QRTEA performance-based RSUs, subsidiary employees (2)

​

20,305

​

​

QRTEA performance-based RSUs, Qurate Retail employees (3)

​

921

​

​

(1) Grants mainly vest equally over three years.
(2) Grants vest equally over three years, subject to the satisfaction of certain performance objectives.
(3) Grants vest one year from the month of grant, subject to the satisfaction of certain performance objectives.
Schedule of number and weighted average GDFV of RSUs granted to certain officers, employees and directors

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

Weighted

​

​

​

Series A

​

Average

​

Series B

​

Average

​

​

​

(000's)

​

GDFV

​

(000's)

​

GDFV

​

RSUs outstanding at January 1, 2024

 

14,691

​

$

3.30

​

353

​

$

5.51

​

Granted

 

3,739

​

$

1.23

​

296

​

$

5.01

​

Vested

 

(5,612)

​

$

3.73

​

(353)

​

$

4.85

​

Forfeited/Cancelled

 

(1,115)

​

$

2.15

​

—

​

$

—

​

RSUs outstanding at March 31, 2024

 

11,703

​

$

2.54

​

296

​

$

5.01

 

Common Class A  
Schedule of number, weighted average exercise price ("WAEP"), Weighted average remaining life and aggregate intrinsic value of the awards

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

​

​

    

Weighted

    

Aggregate

 

​

​

​

​

​

​

​

average

​

intrinsic

​

​

​

Series A

​

​

​

​

remaining

​

value

​

​

​

(000's)

​

WAEP

​

life

​

(millions)

​

Options outstanding at January 1, 2024

 

23,530

​

$

7.72

​

​

​

​

​

​

​

Granted

 

—

​

$

—

​

​

​

​

​

​

​

Exercised

 

—

​

$

—

​

​

​

​

​

​

​

Forfeited/Cancelled

 

(2,849)

​

$

10.87

​

​

​

​

​

​

​

Options outstanding at March 31, 2024

 

20,681

​

$

7.29

 

2.5

years

​

$

—

​

Options exercisable at March 31, 2024

 

18,333

​

$

7.13

 

2.4

years

​

$

—

​

Common Class B  
Schedule of number, weighted average exercise price ("WAEP"), Weighted average remaining life and aggregate intrinsic value of the awards

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

​

​

    

Weighted

    

Aggregate

 

​

​

​

​

​

​

​

average

​

intrinsic

​

​

​

Series B

​

​

​

​

remaining

​

value

​

​

​

(000's)

​

WAEP

​

life

​

(millions)

​

Options outstanding at January 1, 2024

 

723

​

$

12.35

​

​

​

​

​

​

​

Granted

 

—

​

$

—

​

​

​

​

​

​

​

Exercised

 

—

​

$

—

​

​

​

​

​

​

​

Forfeited/Cancelled

​

—

​

$

—

​

​

​

​

​

​

​

Options outstanding at March 31, 2024

 

723

​

$

12.35

 

0.6

years

​

$

—

​

Options exercisable at March 31, 2024

 

723

​

$

12.35

 

0.6

years

​

$

—

​

​

​